Rare Community Profiles: Breaking Barriers: How Nicole and Emma Offer Hope Amidst a Dravet Syndrome Diagnosis
source: pixabay.com

Rare Community Profiles: Breaking Barriers: How Nicole and Emma Offer Hope Amidst a Dravet Syndrome Diagnosis

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Breaking Barriers: How Nicole and Emma Offer Hope Amidst a Dravet Syndrome Diagnosis
Researchers Identify Potential CDKL5 Treatment Target
https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

Researchers Identify Potential CDKL5 Treatment Target

  As it stands today, there are no cures for CDKL5 deficiency disorder. Treatment is symptomatic and supportive, and includes physical, occupational, and speech therapy. CDKL5 deficiency disorder causes seizures,…

Continue Reading Researchers Identify Potential CDKL5 Treatment Target
Rare Community Profiles: Mahnaz Asgharnejad Discusses Data on Soticlestat for LGS and Dravet Syndrome
source: shutterstock.com

Rare Community Profiles: Mahnaz Asgharnejad Discusses Data on Soticlestat for LGS and Dravet Syndrome

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Mahnaz Asgharnejad Discusses Data on Soticlestat for LGS and Dravet Syndrome
FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome
https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome

  Prior to the end of March 2023, ganaxolone had received six separate Orphan Drug designations from the FDA; more recently, as shared in a news release from commercial-stage pharmaceutical…

Continue Reading FDA Grants Orphan Drug Designation to Ganaxolone for Lennox-Gastaut Syndrome
Real-World Data Shows that Epidiolex Significantly Reduces Seizure Frequency in LGS and Dravet Syndrome
https://pixabay.com/en/epilepsy-seizure-stroke-headache-623346/

Real-World Data Shows that Epidiolex Significantly Reduces Seizure Frequency in LGS and Dravet Syndrome

Seizures associated with conditions such as Dravet syndrome and Lennox-Gastaut syndrome (LGS) can be difficult to treat; these seizures may be treatment-averse and may not respond well to current anti-epileptic…

Continue Reading Real-World Data Shows that Epidiolex Significantly Reduces Seizure Frequency in LGS and Dravet Syndrome
Epilepsy Research UK Joins Tuberous Sclerosis Association in Funding Collaboration
Nappiness / Pixabay

Epilepsy Research UK Joins Tuberous Sclerosis Association in Funding Collaboration

  According to a recent announcement, Epilepsy Research UK has announced a funding collaboration with the Tuberous Sclerosis Association which will support the investigation of tuberous sclerosis complex (TSC)-associated epilepsy.…

Continue Reading Epilepsy Research UK Joins Tuberous Sclerosis Association in Funding Collaboration
FDA Approves ZTALMY for CDKL5 Deficiency Disorder
source: pixabay.com

FDA Approves ZTALMY for CDKL5 Deficiency Disorder

Until recently, patients with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) did not have an FDA-approved treatment option. This all changed when the regulatory agency granted approval to ZTALMY, also…

Continue Reading FDA Approves ZTALMY for CDKL5 Deficiency Disorder
Study of the Week: Whole Plant Cannabis Succeeds in Rare Childhood Epilepsies Where CBD and Others Fail
source: pixabay.com

Study of the Week: Whole Plant Cannabis Succeeds in Rare Childhood Epilepsies Where CBD and Others Fail

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Whole Plant Cannabis Succeeds in Rare Childhood Epilepsies Where CBD and Others Fail

Whole-Plant Medicinal Cannabis Found to be Superior to CBD as Treatment for Childhood-Onset Epilepsy

A study conducted by Rayyan Zafar and his colleagues from the Imperial College London was recently published in BMJ Paediatrics Open. This investigation evaluated the efficacy of whole-plant cannabis as a treatment for…

Continue Reading Whole-Plant Medicinal Cannabis Found to be Superior to CBD as Treatment for Childhood-Onset Epilepsy